Rhopressa

Product NDC: 70727-497
11-digit product format: 707270497
Labeler code: 70727
Product ID: 70727-497_82acde68-4935-4dc9-82ff-9ff7f449f893
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: netarsudil
Dosage form: SOLUTION/ DROPS
Route: OPHTHALMIC; TOPICAL
Labeler: Alcon Laboratories, Inc.
Application: NDA208254
Marketing category: NDA
Marketing start: 2017-12-18
Substance: NETARSUDIL MESYLATE
Active strength: .2 mg/mL
Pharmacologic classes: Rho Kinase Inhibitor [EPC], Rho Kinase Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N208254-001	RHOPRESSA	NETARSUDIL MESYLATE	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC		RLD, RS	2017-12-18

Orange Book patents#

Current patent rows page 1 of 1 · 15 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N208254-001	10532993	2026-07-11	U-1524		2020-03-30
N208254-001	10882840	2026-07-11	U-1524		2021-01-22
N208254-001	11021456	2026-07-11	U-1524		2021-06-28
N208254-001	8450344	2026-07-11	U-1524	Drug substance, Drug product	2017-12-21
N208254-001	9096569	2026-07-11	U-1524	Drug substance, Drug product	2017-12-21
N208254-001	10174017	2030-01-27	U-1524	Drug substance, Drug product	2019-03-28
N208254-001	10654844	2030-01-27	U-1524	Drug substance, Drug product	2020-06-10
N208254-001	11028081	2030-01-27	U-1524		2021-06-28
N208254-001	11618748	2030-01-27	U-1524		2023-04-21
N208254-001	8394826	2030-11-10	U-1524	Drug substance, Drug product	2017-12-21
N208254-001	10588901	2034-03-14	U-1524	Drug substance, Drug product	2020-04-15
N208254-001	11020385	2034-03-14	U-1524		2024-07-12
N208254-001	11185538	2034-03-14		Drug product	2021-12-16
N208254-001	9415043	2034-03-14		Drug substance	2017-12-21
N208254-001	9931336	2034-03-14	U-1524	Drug substance, Drug product	2018-04-11

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N208254-001	RHOPRESSA	EQ 0.02% BASE	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	2017-12-18	`f41ea6bd6efb…`

Observed Orange Book patent history#

Patent history page 1 of 14 · 554 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-09-14 22:38:34	2026-08	N208254-001	10532993	2026-07-11	U-1524		2020-03-30	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208254-001	10882840	2026-07-11	U-1524		2021-01-22	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208254-001	11021456	2026-07-11	U-1524		2021-06-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208254-001	8450344	2026-07-11	U-1524	Drug substance, Drug product	2017-12-21	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208254-001	9096569	2026-07-11	U-1524	Drug substance, Drug product	2017-12-21	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208254-001	10174017	2030-01-27	U-1524	Drug substance, Drug product	2019-03-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208254-001	10654844	2030-01-27	U-1524	Drug substance, Drug product	2020-06-10	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208254-001	11028081	2030-01-27	U-1524		2021-06-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208254-001	11618748	2030-01-27	U-1524		2023-04-21	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208254-001	8394826	2030-11-10	U-1524	Drug substance, Drug product	2017-12-21	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208254-001	10588901	2034-03-14	U-1524	Drug substance, Drug product	2020-04-15	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208254-001	11020385	2034-03-14	U-1524		2024-07-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208254-001	11185538	2034-03-14		Drug product	2021-12-16	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208254-001	9415043	2034-03-14		Drug substance	2017-12-21	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208254-001	9931336	2034-03-14	U-1524	Drug substance, Drug product	2018-04-11	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N208254-001	10532993	2026-07-11	U-1524		2020-03-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208254-001	10882840	2026-07-11	U-1524		2021-01-22	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208254-001	11021456	2026-07-11	U-1524		2021-06-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208254-001	8450344	2026-07-11	U-1524	Drug substance, Drug product	2017-12-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208254-001	9096569	2026-07-11	U-1524	Drug substance, Drug product	2017-12-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208254-001	10174017	2030-01-27	U-1524	Drug substance, Drug product	2019-03-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208254-001	10654844	2030-01-27	U-1524	Drug substance, Drug product	2020-06-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208254-001	11028081	2030-01-27	U-1524		2021-06-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208254-001	11618748	2030-01-27	U-1524		2023-04-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208254-001	8394826	2030-11-10	U-1524	Drug substance, Drug product	2017-12-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208254-001	10588901	2034-03-14	U-1524	Drug substance, Drug product	2020-04-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208254-001	11020385	2034-03-14	U-1524		2024-07-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208254-001	11185538	2034-03-14		Drug product	2021-12-16	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208254-001	9415043	2034-03-14		Drug substance	2017-12-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208254-001	9931336	2034-03-14	U-1524	Drug substance, Drug product	2018-04-11	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N208254-001	10532993	2026-07-11	U-1524		2020-03-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N208254-001	10882840	2026-07-11	U-1524		2021-01-22	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N208254-001	11021456	2026-07-11	U-1524		2021-06-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N208254-001	8450344	2026-07-11	U-1524	Drug substance, Drug product	2017-12-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N208254-001	9096569	2026-07-11	U-1524	Drug substance, Drug product	2017-12-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N208254-001	10174017	2030-01-27	U-1524	Drug substance, Drug product	2019-03-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N208254-001	10654844	2030-01-27	U-1524	Drug substance, Drug product	2020-06-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N208254-001	11028081	2030-01-27	U-1524		2021-06-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N208254-001	11618748	2030-01-27	U-1524		2023-04-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N208254-001	8394826	2030-11-10	U-1524	Drug substance, Drug product	2017-12-21	`011fe1cb6892…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N208254-001	NCE	2022-12-18	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N208254-001	NCE	2022-12-18	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N208254-001	NCE	2022-12-18	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N208254-001	NCE	2022-12-18	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N208254-001	NCE	2022-12-18	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N208254-001	NCE	2022-12-18	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N208254-001	NCE	2022-12-18	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N208254-001	NCE	2022-12-18	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N208254-001	NCE	2022-12-18	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N208254-001	NCE	2022-12-18	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N208254-001	NCE	2022-12-18	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N208254-001	NCE	2022-12-18	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N208254-001	NCE	2022-12-18	`ea99ee380514…`
2023-01-26 05:58 UTC	2023-01	N208254-001	NCE	2022-12-18	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N208254-001	NCE	2022-12-18	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N208254-001	NCE	2022-12-18	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N208254-001	NCE	2022-12-18	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N208254-001	NCE	2022-12-18	`cb3db0bc1861…`

Additional Listing Data#

Finished product: Yes
Brand name base: Rhopressa
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
NETARSUDIL MESYLATE	.2 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
VL756B1K0U	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1992868	Internal RxNorm lookup
1992873	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
7d4f0e3a-5b86-4c43-982a-813b22ae7e22	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
203382e3-d801-4f70-866f-ebe316583560	Product name	1	20190624
dc99c89e-d489-4ded-8898-111a91f10877	Product name	1	20180221

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
70727-497-25	Rhopressa	1 in 1 CARTON	SOLUTION/ DROPS	1	17
70727-497-25	Rhopressa	2.5 mL in 1 BOTTLE	SOLUTION/ DROPS	2.5	17
70727-497-99	Rhopressa	1 in 1 CARTON	SOLUTION/ DROPS	1	17
70727-497-99	Rhopressa	2.5 mL in 1 BOTTLE	SOLUTION/ DROPS	2.5	17

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
70727-497-25	ML - Milliliter	70727-497	4820c538-7f5c-4eaf-9ba9-795606dad8ff	1	2018-04-19

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
70727-497	RHOPRESSA (NETARSUDIL) SOLUTION/ DROPS [ALCON LABORATORIES, INC.]	14	Current NDC, Legacy NDC, 4 package rows	20240926_7d4f0e3a-5b86-4c43-982a-813b22ae7e22.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Rhopressa	NETARSUDIL	Alcon Laboratories, Inc.	7d4f0e3a-5b86-4c43-982a-813b22ae7e22	2026-01-20	Warnings, Adverse reactions	Exact identifier application applno (NDA): 208254 application number: NDA208254 ndc (product): 70727-497

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
VL756B1K0U	NETARSUDIL MESYLATE	1422144-42-0	NETARSUDIL MESYLATE
W6I5QDT7QI	NETARSUDIL	1254032-66-0	netarsudil

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1992868	netarsudil 0.02 % Ophthalmic Solution	PSN	7d4f0e3a-5b86-4c43-982a-813b22ae7e22	17
1992873	Rhopressa 0.02 % Ophthalmic Solution	PSN	7d4f0e3a-5b86-4c43-982a-813b22ae7e22	17
1992873	netarsudil 0.2 MG/ML Ophthalmic Solution [Rhopressa]	SBD	7d4f0e3a-5b86-4c43-982a-813b22ae7e22	17
1992868	netarsudil 0.2 MG/ML Ophthalmic Solution	SCD	7d4f0e3a-5b86-4c43-982a-813b22ae7e22	17
1992868	netarsudil 0.02 % Ophthalmic Solution	SY	7d4f0e3a-5b86-4c43-982a-813b22ae7e22	17
1992868	netarsudil 0.2 MG/ML (as netarsudil dimesylate 0.28 MG/ML) Ophthalmic Solution	SY	7d4f0e3a-5b86-4c43-982a-813b22ae7e22	17
1992873	Rhopressa 0.02 % Ophthalmic Solution	SY	7d4f0e3a-5b86-4c43-982a-813b22ae7e22	17
1992873	Rhopressa 0.2 MG/ML (as netarsudil dimesylate 0.28 MG/ML) Ophthalmic Solution	SY	7d4f0e3a-5b86-4c43-982a-813b22ae7e22	17
1992873	Rhopressa 0.2 MG/ML Ophthalmic Solution	SY	7d4f0e3a-5b86-4c43-982a-813b22ae7e22	17

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
70727-497-25	70727049725	1 BOTTLE in 1 CARTON (70727-497-25) / 2.5 mL in 1 BOTTLE	1 bottle	2017-12-18	0000-00-00	No	No	Current
70727-497-99	70727049799	1 BOTTLE in 1 CARTON (70727-497-99) / 2.5 mL in 1 BOTTLE	1 bottle	2017-12-18	0000-00-00	Yes	No	Current